This continuing education program will provide a review of intravenous prostacylin therapy, including patient selection, pharmacology, nursing considerations, and management of chronic prostacyclin infusions. Nurses providing care of patients in the inpatient or outpatient setting will be able to review or learn about the challenges and appropriateness of intravenous prostacylin therapy.
Course Authors
Traci Stewart, RN, MSN
Nurse Clinician Specialist
University of Iowa Hospitals and Clinics
Iowa City, IA
Ryan Hobbs, BS Pharm
Clinical Pharmacy Specialist, Cardiology
University of Iowa Hospitals and Clinics
Iowa City, IA
Review Committee
Robert P. Frantz, MD
Director, Mayo Pulmonary Hypertension Clinic
Director, Cardiovascular Studies Unit
Associate Professor of Medicine, Cardiovascular Diseases and Internal Medicine
Mayo Clinic
Rochester, MN
Jessica Lazar, MPA, PA-C
Director of Program Development
Pulmonary Hypertension Program
The Gerald McGinnis Cardiovascular Institute
Allegheny General Hospital
Pittsburgh, PA
Learning Objectives
Upon successful completion of this course, participants will be able to:
- Discuss the rationale for continuous prostanoid therapy in PAH.
- Describe the characteristics of the different continuous prostanoid therapies and their administration.
- Recognize common side effects of continuous prostanoids.
Accreditation and Credit Designation
Nursing credit is provided through collaboration between ProCE, Inc., Wild Iris Medical Education, Inc., and the Pulmonary Hypertension Association. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour of nurse CE credit.
Instructions for Earning Credit
This activity is a self-study program. Upon entering the activity, participants should read the text, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be asked to complete a post-test and evaluation online. Participants must receive a test score of 100% in order to proceed to the course evaluation; the post-test can be repeated until all questions are answered correctly. All evaluation questions must be completed in order to receive a certificate of credit. If needed, participants may save their answers and complete the course at a later date. Saved courses can be found on the "My Activities" page, accessed via "My Account" at the top of the page.
Faculty Disclosures
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.
Traci Stewart, RN, MSN, indicates no significant relationships to disclose.
Ryan Hobbs, BS Pharm, indicates no significant relationships to disclose.
Disclaimer
The opinions expressed in this program should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
No portion of this activity may be reproduced without the expressed written consent of PHA.
This activity is made possible through unrestricted educational grants from Actelion, Gilead, and United Therapeutics.
Print
Email this page